Mon, April 25, 2022
Sun, April 24, 2022
Fri, April 22, 2022
Thu, April 21, 2022
Wed, April 20, 2022
Tue, April 19, 2022

Nathan Rich Maintained (XRAY) at Hold with Decreased Target to $47 on, Apr 21st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-47-on-apr-21st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Nathan Rich of Goldman Sachs, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Hold with Decreased Target from $59 to $47 on, Apr 21st, 2022.

Nathan has made no other calls on XRAY in the last 4 months.



There are 7 other peers that have a rating on XRAY. Out of the 7 peers that are also analyzing XRAY, 4 agree with Nathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Bednar of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $46 on, Wednesday, April 20th, 2022
  • Michael Cherny of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $49 on, Wednesday, April 20th, 2022
  • Jeffrey Johnson of "Baird" Downgraded from Buy to Hold and Held Target at $48 on, Tuesday, April 19th, 2022
  • John Kreger of "William Blair" Downgraded from Buy to Hold on, Tuesday, April 19th, 2022


These are the ratings of the 3 analyists that currently disagree with Nathan


  • Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $52 on, Wednesday, April 20th, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $67 on, Tuesday, March 1st, 2022
  • Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $67 on, Friday, February 18th, 2022

Publication Contributing Sources